John Craddock

1.2k total citations
10 papers, 646 citations indexed

About

John Craddock is a scholar working on Oncology, Hematology and Epidemiology. According to data from OpenAlex, John Craddock has authored 10 papers receiving a total of 646 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Hematology and 3 papers in Epidemiology. Recurrent topics in John Craddock's work include Hematopoietic Stem Cell Transplantation (4 papers), CAR-T cell therapy research (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). John Craddock is often cited by papers focused on Hematopoietic Stem Cell Transplantation (4 papers), CAR-T cell therapy research (3 papers) and Cytomegalovirus and herpesvirus research (3 papers). John Craddock collaborates with scholars based in United States, Australia and Canada. John Craddock's co-authors include Malcolm K. Brenner, Cliona M. Rooney, An Lu, Martin Pulé, Aaron E. Foster, Adham S. Bear, Helen E. Heslop, Caridad Martinez, Robert A. Krance and Ann M. Leen and has published in prestigious journals such as Blood, American Journal of Ophthalmology and Molecular Therapy.

In The Last Decade

John Craddock

10 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Craddock United States 5 537 231 230 162 127 10 646
Thomas Shum United States 10 476 0.9× 198 0.9× 177 0.8× 161 1.0× 59 0.5× 17 612
Ryo Hanajiri Japan 10 452 0.8× 200 0.9× 170 0.7× 163 1.0× 39 0.3× 29 576
Vicky Torrano United States 6 791 1.5× 389 1.7× 187 0.8× 106 0.7× 109 0.9× 9 893
Theresa Kaeuferle Germany 9 393 0.7× 165 0.7× 126 0.5× 92 0.6× 73 0.6× 15 518
Daniel Hollyman United Kingdom 6 321 0.6× 146 0.6× 161 0.7× 72 0.4× 84 0.7× 10 499
Jacqueline M. Keirnan United States 5 463 0.9× 203 0.9× 213 0.9× 68 0.4× 282 2.2× 6 628
Sandhya Sharma United States 10 641 1.2× 242 1.0× 261 1.1× 118 0.7× 37 0.3× 21 735
Kilian Schober Germany 16 442 0.8× 371 1.6× 154 0.7× 95 0.6× 115 0.9× 38 776
Michael Schmueck‐Henneresse Germany 15 310 0.6× 215 0.9× 212 0.9× 51 0.3× 84 0.7× 32 780
Fenlu Zhu United States 9 485 0.9× 146 0.6× 125 0.5× 197 1.2× 30 0.2× 21 593

Countries citing papers authored by John Craddock

Since Specialization
Citations

This map shows the geographic impact of John Craddock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Craddock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Craddock more than expected).

Fields of papers citing papers by John Craddock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Craddock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Craddock. The network helps show where John Craddock may publish in the future.

Co-authorship network of co-authors of John Craddock

This figure shows the co-authorship network connecting the top 25 collaborators of John Craddock. A scholar is included among the top collaborators of John Craddock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Craddock. John Craddock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wu, Meng-Fen, Tao Wang, Erin Doherty, et al.. (2023). Blinatumomab Therapy Is Associated with Favorable Outcomes after Allogeneic Hematopoietic Cell Transplantation in Pediatric Patients with B Cell Acute Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 30(2). 217–227. 4 indexed citations
2.
Friend, Brian D., Ibrahim N. Muhsen, Shreeya Patel, et al.. (2022). Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma. Bone Marrow Transplantation. 57(4). 579–585. 1 indexed citations
3.
Friend, Brian D., Ghadir Sasa, Bilal Omer, et al.. (2021). Matched related hematopoietic cell transplant for sickle cell disease with alemtuzumab: the Texas Children’s Hospital experience. Bone Marrow Transplantation. 56(11). 2797–2803. 4 indexed citations
4.
Doherty, Erin, Michele S. Redell, Ghadir Sasa, et al.. (2019). Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Myeloid Leukemia in the Contemporary Era. Blood. 134(Supplement_1). 2056–2056. 3 indexed citations
5.
Craddock, John, Mark J. Abzug, Donna Curtis, et al.. (2016). Cytomegalovirus Retinitis in Pediatric Stem Cell Transplants: Report of a Recent Cluster and the Development of a Screening Protocol. American Journal of Ophthalmology. 175. 8–15. 12 indexed citations
6.
Ponce, Doris M., Mary Eapen, Rodney Sparapani, et al.. (2015). In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children. Biology of Blood and Marrow Transplantation. 21(12). 2173–2179. 13 indexed citations
7.
Gerdemann, Ulrike, Usha L. Katari, Αναστασία Παπαδοπούλου, et al.. (2013). Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant. Molecular Therapy. 21(11). 2113–2121. 171 indexed citations
8.
Craddock, John, An Lu, Adham S. Bear, et al.. (2010). Enhanced Tumor Trafficking of GD2 Chimeric Antigen Receptor T Cells by Expression of the Chemokine Receptor CCR2b. Journal of Immunotherapy. 33(8). 780–788. 427 indexed citations
9.
Craddock, John & Helen E. Heslop. (2008). Adoptive cellular therapy with T cells specific for EBV-derived tumor antigens. PubMed. 3(1). 33–41. 10 indexed citations
10.
Leen, Ann M., Carolina Colli Cruz, John Craddock, et al.. (2008). The “Side-Population” of Human Lymphoma Cells Have Increased Chemo-Resistance, Stem-Cell Like Properties and Are Potential Targets for Immunotherapy. Blood. 112(11). 2620–2620. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Shum Breakdown of academic impact, for papers by Ryo Hanajiri Breakdown of academic impact, for papers by Vicky Torrano Breakdown of academic impact, for papers by Theresa Kaeuferle Breakdown of academic impact, for papers by Daniel Hollyman Breakdown of academic impact, for papers by Jacqueline M. Keirnan Breakdown of academic impact, for papers by Sandhya Sharma Breakdown of academic impact, for papers by Kilian Schober Breakdown of academic impact, for papers by Michael Schmueck‐Henneresse Breakdown of academic impact, for papers by Fenlu Zhu
Rankless by CCL
2026